South Shore Eye Care   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Wantagh NY United States

Organization Overview

First Clinical Trial
2007
NCT00469573
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

South Shore Eye Care LLP | South Shore Eye Center | South Shore Eye Center, LLP

Active Ingredients

Drugs in Phase 4 Trials (1)

carboxymethyl cellulose (1 trial)

Drugs in Phase 2 Trials (1)

loteprednol (lotemax) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blepharitis (Phase 2)

Dry Eye Syndromes (Phase 4)

Eye Diseases (Phase 2)

Keratoconjunctivitis (Phase 2)

Keratoconjunctivitis Sicca (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2